Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States; Alcohol & Drug Abuse Center of Excellence, LSU Health Sciences Center, New Orleans, LA, United States; Southeast Louisiana Veterans Health Care System, New Orleans, LA, United States.
Department of Physiology, LSU Health Sciences Center, New Orleans, LA, United States; Alcohol & Drug Abuse Center of Excellence, LSU Health Sciences Center, New Orleans, LA, United States.
Neuropharmacology. 2023 Jun 15;231:109512. doi: 10.1016/j.neuropharm.2023.109512. Epub 2023 Mar 21.
The current opioid epidemic is a national health crisis marked by skyrocketing reports of opioid misuse and overdose deaths. Despite the risks involved, prescription opioid analgesics are the most powerful and effective medications for treating pain. There is a clear need to investigate the risk of opioid misuse liability in male and female adults experiencing chronic pain. In the present study, we tested the hypothesis that chronic inflammatory pain would increase fentanyl intake, motivation to acquire fentanyl, and drug seeking in the absence of fentanyl in rats. Fentanyl intake, motivation for fentanyl, and drug seeking were tested under limited and extended access conditions using intravenous fentanyl self-administration. Fos activity in ventral tegmental area (VTA) dopamine neurons following intravenous fentanyl challenge (35 μg/kg) was examined using immunohistochemistry. Finally, we tested whether low-dose fentanyl supports development of conditioned place preference under an inflammatory pain state in rats. Contrary to our hypothesis, fentanyl self-administration and VTA Fos activity were unaffected by inflammatory pain status. During acquisition, males exhibited increased fentanyl intake compared to females. Animals given extended access to fentanyl escalated fentanyl intake over time, while animals given limited access did not. Males given extended access to fentanyl demonstrated a greater increase in fentanyl intake over time compared to females. During the dose-response test, females given limited access to fentanyl demonstrated increased motivation to acquire fentanyl compared to males. Both sexes displayed significant increases in responding for fentanyl as unit fentanyl doses were lowered. Following fentanyl challenge, females exhibited higher numbers of Fos-positive non-dopaminergic VTA neurons compared to males. Using conditioned place preference, we found that chronic inflammatory pain promotes fentanyl preference in males, but not females. These findings suggest that established fentanyl self-administration is resistant to change by inflammatory pain manipulation in both sexes, but chronic inflammatory pain increases the rewarding properties of low-dose fentanyl in males.
当前的阿片类药物流行是一场全国性的健康危机,其特点是阿片类药物滥用和过量死亡的报告急剧上升。尽管存在风险,但处方类阿片类镇痛药是治疗疼痛最有效和最有效的药物。显然需要研究慢性疼痛的成年男性和女性滥用阿片类药物的风险。在本研究中,我们检验了以下假设:慢性炎症性疼痛会增加芬太尼的摄入、获得芬太尼的动机以及在没有芬太尼的情况下觅药。通过静脉芬太尼自我给药,在有限和扩展的访问条件下测试芬太尼的摄入、芬太尼的动机和觅药。使用免疫组织化学检测静脉芬太尼挑战(35μg/kg)后腹侧被盖区(VTA)多巴胺神经元中的 Fos 活性。最后,我们测试了低剂量芬太尼是否在炎症性疼痛状态下支持大鼠条件性位置偏好的发展。与我们的假设相反,芬太尼自我给药和 VTA Fos 活性不受炎症性疼痛状态的影响。在获得阶段,雄性的芬太尼摄入量高于雌性。给予芬太尼扩展访问的动物随着时间的推移增加了芬太尼的摄入量,而给予有限访问的动物则没有。与雌性相比,给予芬太尼扩展访问的雄性随着时间的推移芬太尼摄入量增加更多。在剂量反应测试中,与雄性相比,给予有限芬太尼访问的雌性表现出增加获得芬太尼的动机。随着单位芬太尼剂量的降低,两种性别都表现出对芬太尼的反应显著增加。在芬太尼挑战后,雌性的 Fos 阳性非多巴胺能 VTA 神经元数量高于雄性。使用条件性位置偏好,我们发现慢性炎症性疼痛会促进雄性对芬太尼的偏好,但不会促进雌性。这些发现表明,在两性中,已建立的芬太尼自我给药不受炎症性疼痛操作的改变,但慢性炎症性疼痛会增加男性对低剂量芬太尼的奖赏特性。